Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Flockhart

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Clinical Pharmacokinetics|January 1, 1995
Drug interactions and the cytochrome P450 system. The role of cytochrome P450 2C19D A Flockhart
Methods in Enzymology|January 1, 1983
Removal of phosphate from proteins by the reverse reactionD A Flockhart
Journal of Clinical Psychopharmacology|April 1, 1996
Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic?D A Flockhart
Journal of Forensic Sciences|February 13, 1999
Commentary on McIntyre IM, King CV, Staikos V, Gall J, Drummer OH. A fatality involving moclobemide, sertraline and pimozide. J Forensic Sci 1997;42:951-53Z Desta, D A Flockhart
Biochemical Society Transactions|October 1, 1979
Lack of effect of insulin on guanosine 3':5'-cyclic monophosphate content of insulin-sensitive rat hepatocytes [proceedings]D A Flockhart, K Siddle
Clinical Pharmacology and Therapeutics|April 20, 2012
The need for translational research on drug-drug interactionsS Hennessy, D A Flockhart
The Pharmacogenomics Journal|March 12, 2003
Cytochrome P450 3A pharmacogenetics: the road that needs traveledD A Flockhart, J M Rae
CRC Critical Reviews in Biochemistry|February 1, 1982
Regulatory mechanisms in the control of protein kinasesD A Flockhart, J D Corbin
Clinical Pharmacology and Therapeutics|July 11, 2008
Finding the right research question: quality science depends on quality careersD A Flockhart, D R Abernethy
Circulation|April 12, 2000
Molecular basis of cardiovascular drug metabolism: implications for predicting clinically important drug interactionsD R Abernethy, D A Flockhart
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Clinical Pharmacokinetics|January 1, 1995
Drug interactions and the cytochrome P450 system. The role of cytochrome P450 2C19D A Flockhart
Methods in Enzymology|January 1, 1983
Removal of phosphate from proteins by the reverse reactionD A Flockhart
Journal of Clinical Psychopharmacology|April 1, 1996
Drug interactions, cardiac toxicity, and terfenadine: from bench to clinic?D A Flockhart
Journal of Forensic Sciences|February 13, 1999
Commentary on McIntyre IM, King CV, Staikos V, Gall J, Drummer OH. A fatality involving moclobemide, sertraline and pimozide. J Forensic Sci 1997;42:951-53Z Desta, D A Flockhart
Biochemical Society Transactions|October 1, 1979
Lack of effect of insulin on guanosine 3':5'-cyclic monophosphate content of insulin-sensitive rat hepatocytes [proceedings]D A Flockhart, K Siddle
Clinical Pharmacology and Therapeutics|April 20, 2012
The need for translational research on drug-drug interactionsS Hennessy, D A Flockhart
The Pharmacogenomics Journal|March 12, 2003
Cytochrome P450 3A pharmacogenetics: the road that needs traveledD A Flockhart, J M Rae
CRC Critical Reviews in Biochemistry|February 1, 1982
Regulatory mechanisms in the control of protein kinasesD A Flockhart, J D Corbin
Clinical Pharmacology and Therapeutics|July 11, 2008
Finding the right research question: quality science depends on quality careersD A Flockhart, D R Abernethy
Circulation|April 12, 2000
Molecular basis of cardiovascular drug metabolism: implications for predicting clinically important drug interactionsD R Abernethy, D A Flockhart
Pageof 10